awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34574985-C5AB03B0-89F2-45EA-950A-F81852A857F5
Q34574985-C5AB03B0-89F2-45EA-950A-F81852A857F5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34574985-C5AB03B0-89F2-45EA-950A-F81852A857F5
Endocrine side effects of broad-acting kinase inhibitors.
P2860
Q34574985-C5AB03B0-89F2-45EA-950A-F81852A857F5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34574985-C5AB03B0-89F2-45EA-950A-F81852A857F5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
83d64bfc4ad03ff3bbaaf1982b05e9b68664f656
P2860
Food and Drug Administration drug approval summary: Sunitinib malate for the treatment of gastrointestinal stromal tumor and advanced renal cell carcinoma.